Search results

Osteoporosis is a major public health issue, and it has been estimated that total annual cost of osteoporosis/osteopenia in Australia is around $2,754 million.

Join experts from ANSTO and industry to explore how quantum sensing is transforming nuclear technologies, enhancing safety, strengthening security and unlocking powerful new capabilities for the future.

Tool developed for producing F-18 radiopharmaceuticals for PET imaging.

Research reports for the first time how solid methane and nitrogen expand in response to temperature changes and resolves an historic ambiguity relating to the structure of nitrogen.

In part 1 of this two-part series, ANSTO scientists from across the organisation became film critics to review Christopher Nolan’s new movie, Oppenheimer, which explores the life of the director of the Manhattan Project to develop an atomic weapon.

Collaboration across the Tasman has enabled Australian and New Zealand researchers and scientists to shed light on a protein involved in diseases such as Parkinson’s disease, gastric cancer and melanoma.

ANSTO is dedicated to identifying opportunities for the application of knowledge and technology developed by the organisation for a wide range of industry applications.

Environmental scientist with a passion for fieldwork and a lifelong commitment to scientific excellence

A revised model has been developed that can more accurately predict the actual service life of an industrial component.

In Part 2 of our series exploring the world of nuclear science and technology at ANSTO, we share more detailed information about the nuclear scientist’s toolkit.

Congress marks watershed moment for nuclear medicine and ANSTO

The X-ray fluorescence microspectroscopy beamline offers a range of x-ray absorption and fluorescence spectroscopy techniques at submicron length-scales. The beamline has two microscopes optimised for complementary studies.